Cypress Wealth Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $893K | Buy |
1,361
+161
| +13% | +$95.6K | 0.11% | 149 |
|
|
2026
Q2 | $602K | Sell |
1,200
-196
| -14% | -$94.1K | 0.07% | 207 |
|
|
2026
Q1 | $686K | Buy |
1,396
+108
| +8% | +$58.6K | 0.1% | 169 |
|
|
2025
Q4 | $747K | Sell |
1,288
-23
| -2% | -$13K | 0.1% | 151 |
|
|
2025
Q3 | $636K | Sell |
1,311
-105
| -7% | -$48.9K | 0.1% | 154 |
|
|
2025
Q2 | $574K | Buy |
1,416
+755
| +114% | +$316K | 0.1% | 157 |
|
|
2025
Q1 | $329K | Sell |
661
-95
| -13% | -$51.5K | 0.07% | 200 |
|
|
2024
Q4 | $393K | Sell |
756
-57
| -7% | -$31.3K | 0.08% | 175 |
|
|
2024
Q3 | $503K | Buy |
813
+6
| +0.7% | +$3.55K | 0.1% | 151 |
|
|
2024
Q2 | $446K | Buy |
807
+17
| +2% | +$9.7K | 0.1% | 155 |
|
|
2024
Q1 | $459K | Buy |
790
+6
| +0.8% | +$3.37K | 0.11% | 149 |
|
|
2023
Q4 | $416K | Hold |
784
| – | – | 0.1% | 158 |
|
|
2023
Q3 | $397K | Hold |
784
| – | – | 0.11% | 156 |
|
|
2023
Q2 | $412K | Sell |
784
-59
| -7% | -$31.8K | 0.11% | 155 |
|
|
2023
Q1 | $486K | Hold |
843
| – | – | 0.14% | 128 |
|
|
2022
Q4 | $464K | Buy |
843
+40
| +5% | +$21.2K | 0.15% | 126 |
|
|
2022
Q3 | $420K | Sell |
803
-2
| -0.2% | -$1.12K | 0.14% | 130 |
|
|
2022
Q2 | $437K | Hold |
805
| – | – | 0.14% | 127 |
|
|
2022
Q1 | $475K | Hold |
805
| – | – | 0.13% | 126 |
|
|
2021
Q4 | $537K | Sell |
805
-16
| -2% | -$10K | 0.15% | 106 |
|
|
2021
Q3 | $469K | Sell |
821
-8
| -1% | -$4.39K | 0.14% | 119 |
|
|
2021
Q2 | $418K | Sell |
829
-62
| -7% | -$29.3K | 0.11% | 158 |
|
|
2021
Q1 | $407K | Sell |
891
-10
| -1% | -$4.77K | 0.09% | 178 |
|
|
2020
Q4 | $420K | Buy |
+901
| New | +$422K | 0.09% | 167 |
|
|
2020
Q3 | – | Sell |
-711
| Closed | -$294K | – | 474 |
|
|
2020
Q2 | $258K | Hold |
711
| – | – | 0.06% | 222 |
|
|
2020
Q1 | $202K | Buy |
711
+19
| +3% | +$5.99K | 0.06% | 225 |
|
|
2019
Q4 | $225K | Sell |
692
-30
| -4% | -$9.1K | 0.06% | 226 |
|
|
2019
Q3 | $210K | Sell |
722
-184
| -20% | -$52.7K | 0.06% | 231 |
|
|
2019
Q2 | $266K | Hold |
906
| – | – | 0.08% | 206 |
|
|
2019
Q1 | $248K | Buy |
906
+12
| +1% | +$2.99K | 0.08% | 206 |
|
|
2018
Q4 | $200K | Buy |
894
+15
| +2% | +$3.52K | 0.08% | 204 |
|
|
2018
Q3 | $215K | Buy |
+879
| New | +$202K | 0.08% | 201 |
|
Other funds holding TMO
Cypress Wealth Services's TMO Position: Q3 2026 in Review
Cypress Wealth Services increased its Thermo Fisher Scientific (TMO) stake by 13% in Q3 2026, buying an estimated $95.6K and bringing the position to 1,361 shares worth $893K. The position accounts for 0.11% of the portfolio, ranked #149.
Cypress Wealth Services first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Cypress Wealth Services held 1,361 shares of Thermo Fisher Scientific worth $893K as of Q3 2026.
- Cypress Wealth Services bought 161 Thermo Fisher Scientific shares in Q3 2026, an estimated $95.6K.
- Thermo Fisher Scientific made up 0.11% of Cypress Wealth Services's portfolio in Q3 2026, its #149 holding.
- Cypress Wealth Services first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Cypress Wealth Services's 13F filing for Q3 2026, filed 21 Oct 2026.